Glympse Bio’s tunable biosensors are poised to be a game-changing diagnostic tool in 2021. These noninvasive biosensors report real-time biological changes for protease-mediated disease, which are notoriously difficult to measure and track in vivo. With the data they provide, physicians can more accurately fibrotic diseases, oncology, and related conditions, and drug developers can monitor treatment […]

2020 was a record year for initial public offerings in the US, with 442 logged as of December 14. Yet only a handful of those were companies founded and led by women, according to research by Business Insider and information provided by Nasdaq. Historically, only about 20 women seem to have founded and led a […]

Sepsis is a serious medical condition that manifests with a dysregulated immune response to an infection in the bloodstream, and is a major cause of morbidity and mortality worldwide. Many non-infectious conditions can lead to a state of hyper-inflammation known as the systemic inflammatory response syndrome (SIRS), which clinically can look very similar to sepsis. […]